- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic plaque psoriasis (CPP)
- Meeting Date: May 2025
Guselkumab – May 2025
Guselkumab: Injection 100 mg in 1 mL single use pre-filled pen; Tremfya®
Public Summary Documents
Related Public Summary Documents
Last updated
9 May 2025
